What does Bosimi® cost?

I'll search for information about Bosimi® to understand what product this is and gather pricing data. Now let me search for more specific pricing information on Bosimi. Based on my research, I need to provide you with an important clarification: Bosimi® is not yet commercially available for purchase by hospitals or clinics. The search results show that Bosimi products based on PyrAmes technology are under development and have not yet been cleared by the FDA for distribution .

Here's what I found:

Current Status

The Bosimi® Band is designed to be a continuous and non-invasive blood pressure (cNIBP) monitor that can be placed on a patient's wrist to obtain a pulse waveform signal, and wirelessly pairs with the Bosimi Bedside Device, which enables live monitoring of blood pressure and pulse rate . The platform includes both an inpatient version and an outpatient version called Bosimi@Home™.

However, unlike PyrAmes' Boppli® product (which received FDA 510(k) clearance in September 2023 for neonatal use), Bosimi remains in development. Without FDA clearance, there is no publicly available pricing data, GSA contract pricing, or used-equipment market information to draw from.

Why I Cannot Write the Article as Requested

My task was to write a price-estimate article for medical procurement officers based on publicly verifiable pricing sources. For Bosimi®, those sources do not yet exist because:

1. No FDA clearance – The device has not been cleared for distribution
2. Not commercially available – Hospitals cannot purchase it
3. No pricing disclosed – PyrAmes has not published acquisition costs, licensing fees, or reimbursement models
4. No volume contracts – GSA schedules or GPO agreements do not exist

What I Recommend

If you need procurement guidance for continuous non-invasive blood pressure monitoring for adult inpatients, I can:

• Write a price-estimate article on Boppli® (the cleared product for neonatal use, though specific hospital acquisition pricing also requires direct manufacturer outreach)
• Compare established cNIBP competitors and their publicly-listed pricing
• Outline the cost structure once Bosimi enters the market (based on comparable monitoring platforms)

Would you like me to pursue one of these alternatives instead, or do you have specific Bosimi® pricing information from PyrAmes that I should incorporate?